Jeffrey H Newcorn Selected Research

Jeffrey H Newcorn Research Topics

Disease

95	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2022 - 04/2002
5	Substance-Related Disorders (Drug Abuse) 10/2018 - 11/2006
3	Oppositional Defiant Disorder 01/2020 - 03/2005
3	Mental Disorders (Mental Disorder) 02/2016 - 09/2007
2	Sleepiness 01/2019 - 10/2018
2	Disorders of Excessive Somnolence (Hypersomnia) 01/2019 - 10/2018
2	Antisocial Personality Disorder (Antisocial Personality) 12/2018 - 07/2006
2	Fatigue 01/2018 - 12/2012
2	Nausea 01/2018 - 12/2012
1	Cardiotoxicity 01/2021
1	Sluggish Cognitive Tempo 01/2021
1	Sleep Wake Disorders 01/2020
1	Narcolepsy 01/2020
1	Conduct Disorder (Conduct Disorders) 12/2018
1	Constipation 01/2018
1	Alcoholism (Alcohol Abuse) 08/2017
1	Mood Disorders (Mood Disorder) 02/2016
1	Hypertension (High Blood Pressure) 06/2014
1	Pre-Eclampsia (Preeclampsia) 06/2014
1	Headache (Headaches) 12/2012
1	Wounds and Injuries (Trauma) 10/2011
1	Bulimia Nervosa 04/2010
1	Autistic Disorder (Autism) 02/2010
1	Major Depressive Disorder (Major Depressive Disorders) 04/2004
1	Confusion (Bewilderment) 07/2002

Drug/Important Bio-Agent (IBA)

22	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 07/2017 - 07/2002
19	Methylphenidate (Ritalin)FDA LinkGeneric 03/2022 - 07/2002
16	Pemetrexed (MTA)FDA Link 02/2022 - 05/2002
11	Guanfacine (Tenex)FDA LinkGeneric 01/2020 - 01/2003
5	Amphetamine (Amfetamine)FDA LinkGeneric 01/2019 - 04/2002
5	Pharmaceutical PreparationsIBA 10/2018 - 07/2002
4	Lisdexamfetamine Dimesylate FDA Link 01/2021 - 11/2017
4	Biological ProductsIBA 01/2020 - 11/2006
4	Dopamine (Intropin)FDA LinkGeneric 07/2014 - 09/2009
3	metadoxineIBA 01/2020 - 12/2012
3	Serotonin (5 Hydroxytryptamine)IBA 02/2010 - 05/2002
2	ViloxazineIBA 01/2021 - 01/2020
2	Hypnotics and Sedatives (Sedatives)IBA 01/2019 - 10/2018
2	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2018 - 10/2011
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2015 - 05/2006
2	Adrenergic Receptors (Adrenergic Receptor)IBA 03/2013 - 08/2009
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2013 - 11/2010
2	Dexmethylphenidate Hydrochloride FDA LinkGeneric 12/2011 - 08/2007
2	SaltsIBA 12/2011 - 04/2002
1	AmphetaminesIBA 10/2021
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2021
1	Capsules (Microcapsules)IBA 01/2020
1	IronIBA 01/2020
1	4-aminospiroperidolIBA 12/2018
1	Mazindol (Mazanor)FDA Link 01/2018
1	Adenosine Monophosphate (AMP)IBA 08/2017
1	TabletsIBA 08/2017
1	Biomarkers (Surrogate Marker)IBA 07/2017
1	Dopamine Agents (Dopaminergic Agents)IBA 07/2017
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 10/2016
1	Excipients (Suspending Agents)IBA 02/2016
1	Antipsychotic Agents (Antipsychotics)IBA 02/2016
1	trans-sodium crocetinate (crocetin)IBA 12/2015
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 03/2015
1	Dopamine Receptors (Dopamine Receptor)IBA 07/2014
1	Proteins (Proteins, Gene)FDA Link 06/2014
1	TEMPOIBA 09/2013
1	Clonidine (ST 155)FDA LinkGeneric 06/2013
1	Delayed-Action PreparationsIBA 06/2013
1	Cocaine (Cocaine HCl)IBA 01/2013
1	Aligeron (AS 2)IBA 12/2012
1	Therapeutic UsesIBA 09/2012
1	galantide (M 15)IBA 10/2011
1	3' Untranslated Regions (3' UTR)IBA 11/2010
1	Central Nervous System StimulantsIBA 01/2010
1	LigandsIBA 09/2009
1	4,4'-dibenzamido-2,2'-stilbenedisulfonic acidIBA 03/2009
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 06/2008
1	Controlled SubstancesIBA 08/2007
1	FenfluramineIBA 05/2007
1	Fluoxetine (Prozac)FDA LinkGeneric 09/2005
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 04/2004
1	alpha-2 Adrenergic ReceptorsIBA 01/2003
1	Growth Hormone (Somatotropin)IBA 01/2003
1	Tamoxifen FDA LinkGeneric 07/2002
1	ProlactinIBA 05/2002

Therapy/Procedure

21	Combined Modality Therapy 02/2022 - 05/2002
6	Drug Therapy (Chemotherapy) 01/2022 - 07/2005
4	Therapeutics 01/2021 - 07/2002
1	Treatment Delay 01/2021
1	Off-Label Use 01/2020
1	Ambulatory Care (Outpatient Care) 09/2011
1	Aftercare (After-Treatment) 05/2009
1	Oral Administration 01/2003